Quick Takeaways
- STROME MEZZANINE FUND, LP filed SCHEDULE 13D/A for Zivo Bioscience, Inc. Common Stock, par value $.001 per share (ZIVO).
- Disclosed ownership: 12%.
- Date of event: 26 Dec 2024.
STROME MEZZANINE FUND, LP - 26 Dec 2024 SCHEDULE 13D/A Report for Zivo Bioscience, Inc. Common Stock, par value $.001 per share (ZIVO)
- Filing Manager
- STROME MEZZANINE FUND, LP
- Reporting Manager
- Mark E. Strome
- Symbol
- ZIVO
- Shares outstanding
- 3,629,951 shares
- Disclosed Ownership
- 442,854 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13D/A
- Filing time
- 07 Jan 2025, 18:01:58 UTC
- Date of event
- 26 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"STROME MEZZANINE FUND, LP disclosed 12% ownership in Zivo Bioscience, Inc. Common Stock, par value $.001 per share (ZIVO) on 26 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Jan 2025, 18:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mark E. Strome | 12% | 442,854 | 220,349 | 222,505 | /s/ Mark E. Strome | Mark E. Strome | 0000919484 |
| Strome Group, Inc. | 6.1% | 222,505 | 0 | 222,505 | /s/ Mark E. Strome | Mark E. Strome/President | |
| Strome Investment Management, LP | 6.1% | 222,505 | 0 | 222,505 | Strome Group, Inc. | General Partner | |
| Strome Mezzanine Fund, LP | 1.2% | 45,064 | 0 | 45,064 | Strome Investment Management, LP | General Partner | 0001713153 |
| Strome Mezzanine Fund II, LP | 4.6% | 165,000 | 0 | 165,000 | Strome Investment Management, LP | General Partner |